142 related articles for article (PubMed ID: 27145964)
1. ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells.
Fukushima H; Yasumoto M; Ogasawara S; Akiba J; Kitasato Y; Nakayama M; Naito Y; Ishida Y; Okabe Y; Yasunaga M; Horiuchi H; Sakamoto E; Itadani H; Mizuarai S; Oie S; Yano H
Mol Cancer; 2016 May; 15(1):32. PubMed ID: 27145964
[TBL] [Abstract][Full Text] [Related]
2. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma.
Peng T; Sun F; Yang JC; Cai MH; Huai MX; Pan JX; Zhang FY; Xu LM
World J Gastroenterol; 2024 May; 30(19):2575-2602. PubMed ID: 38817665
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery.
Sergeant G; van Eijsden R; Roskams T; Van Duppen V; Topal B
BMC Cancer; 2012 Nov; 12():527. PubMed ID: 23157946
[TBL] [Abstract][Full Text] [Related]
4. Single-cell transcriptome reveals the heterogeneity of malignant ductal cells and the prognostic value of REG4 and SPINK1 in primary pancreatic ductal adenocarcinoma.
Ji Y; Xu Q; Wang W
PeerJ; 2024; 12():e17350. PubMed ID: 38827297
[TBL] [Abstract][Full Text] [Related]
5. TGFβ1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma.
Glazer ES; Welsh E; Pimiento JM; Teer JK; Malafa MP
Oncotarget; 2017 Jan; 8(1):999-1006. PubMed ID: 27895310
[TBL] [Abstract][Full Text] [Related]
6. Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling.
Chen Q; Jiang LY; Cao C; Liu FY; Li DR; Wu PF; Jiang KR
Mol Carcinog; 2024 May; 63(5):938-950. PubMed ID: 38353288
[TBL] [Abstract][Full Text] [Related]
7. PIMREG, a Marker of Proliferation, Facilitates Aggressive Development of Cholangiocarcinoma Cells Partly Through Regulating Cell Cycle-Related Markers.
Jiang ZM; Li HB; Chen SG
Technol Cancer Res Treat; 2020; 19():1533033820979681. PubMed ID: 33356974
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics analysis of intra-tumoural and inter-tumoural heterogeneity in pancreatic ductal adenocarcinoma.
Liu X; Wang W; Liu X; Zhang Z; Yu L; Li R; Guo D; Cai W; Quan X; Wu H; Dai M; Liang Z
Clin Transl Med; 2022 Jan; 12(1):e670. PubMed ID: 35061935
[TBL] [Abstract][Full Text] [Related]
9. Expression landscape of cancer-FOXP3 and its prognostic value in pancreatic adenocarcinoma.
Gong R; Wang J; Xing Y; Wang J; Chen X; Lei K; Yu Q; Zhao C; Li S; Zhang Y; Wang H; Ren H
Cancer Lett; 2024 May; 590():216838. PubMed ID: 38561039
[TBL] [Abstract][Full Text] [Related]
10. Detailing the ultrastructure's increase of prion protein in pancreatic adenocarcinoma.
Bianchini M; Giambelluca MA; Scavuzzo MC; Di Franco G; Guadagni S; Palmeri M; Furbetta N; Gianardi D; Funel N; Ricci C; Gaeta R; Pollina LE; Falcone A; Vivaldi C; Di Candio G; Biagioni F; Busceti CL; Morelli L; Fornai F
World J Gastroenterol; 2021 Nov; 27(42):7324-7339. PubMed ID: 34876792
[TBL] [Abstract][Full Text] [Related]
11. Proteogenomic characterization of pancreatic ductal adenocarcinoma.
Cao L; Huang C; Cui Zhou D; Hu Y; Lih TM; Savage SR; Krug K; Clark DJ; Schnaubelt M; Chen L; da Veiga Leprevost F; Eguez RV; Yang W; Pan J; Wen B; Dou Y; Jiang W; Liao Y; Shi Z; Terekhanova NV; Cao S; Lu RJ; Li Y; Liu R; Zhu H; Ronning P; Wu Y; Wyczalkowski MA; Easwaran H; Danilova L; Mer AS; Yoo S; Wang JM; Liu W; Haibe-Kains B; Thiagarajan M; Jewell SD; Hostetter G; Newton CJ; Li QK; Roehrl MH; Fenyö D; Wang P; Nesvizhskii AI; Mani DR; Omenn GS; Boja ES; Mesri M; Robles AI; Rodriguez H; Bathe OF; Chan DW; Hruban RH; Ding L; Zhang B; Zhang H;
Cell; 2021 Sep; 184(19):5031-5052.e26. PubMed ID: 34534465
[TBL] [Abstract][Full Text] [Related]
12. PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression.
Agarwal S; Chakravarthi BVSK; Kim HG; Gupta N; Hale K; Balasubramanya SAH; Oliver PG; Thomas DG; Eltoum IA; Buchsbaum DJ; Manne U; Varambally S
Transl Oncol; 2020 Jul; 13(7):100776. PubMed ID: 32422575
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Notch3 links TIMP3 inhibition to suppress aggressive phenotypes of pancreatic ductal adenocarcinoma.
Chiu TJ; Chen YJ; Lan J; Chen YY; Chen YC; Lin HW; Tsai HT; Lin YS; Hsiao CC; Chen CH
Am J Cancer Res; 2021; 11(11):5609-5624. PubMed ID: 34873483
[TBL] [Abstract][Full Text] [Related]
14. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk.
Zhu J; Shu X; Guo X; Liu D; Bao J; Milne RL; Giles GG; Wu C; Du M; White E; Risch HA; Malats N; Duell EJ; Goodman PJ; Li D; Bracci P; Katzke V; Neale RE; Gallinger S; Van Den Eeden SK; Arslan AA; Canzian F; Kooperberg C; Beane Freeman LE; Scelo G; Visvanathan K; Haiman CA; Le Marchand L; Yu H; Petersen GM; Stolzenberg-Solomon R; Klein AP; Cai Q; Long J; Shu XO; Zheng W; Wu L
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1501-1508. PubMed ID: 32439797
[TBL] [Abstract][Full Text] [Related]
15. Role of Wnt5b-Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells.
Yamauchi N; Otsuka M; Ishikawa T; Kakeji Y; Kikuchi A; Masuda A; Kodama Y; Minami Y; Kamizaki K
Genes Cells; 2024 Mar; ():. PubMed ID: 38531660
[TBL] [Abstract][Full Text] [Related]
16. RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients.
Muniz VP; Askeland RW; Zhang X; Reed SM; Tompkins VS; Hagen J; McDowell BD; Button A; Smith BJ; Weydert JA; Mezhir JJ; Quelle DE
Genes Cancer; 2013 Jul; 4(7-8):273-84. PubMed ID: 24167655
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma.
Xi T; Zhang G
PLoS One; 2018; 13(3):e0193427. PubMed ID: 29596435
[TBL] [Abstract][Full Text] [Related]
18. Prevention of pancreatic cancer in a hamster model by cAMP decrease.
Banerjee J; Papu John AM; Al-Wadei MH; Schuller HM
Oncotarget; 2016 Jul; 7(28):44430-44441. PubMed ID: 27281617
[TBL] [Abstract][Full Text] [Related]
19. The immune response to a fungus in pancreatic cancer samples.
Brayer KJ; Hanson JA; Cingam S; Martinez C; Ness SA; Rabinowitz I
bioRxiv; 2023 Mar; ():. PubMed ID: 37034706
[TBL] [Abstract][Full Text] [Related]
20. Excavation of gene markers associated with pancreatic ductal adenocarcinoma based on interrelationships of gene expression.
Zhang ZY; Sun ZJ; Gao D; Hao YD; Lin H; Liu F
IET Syst Biol; 2024 Mar; ():. PubMed ID: 38530028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
